Nd mainly for cancer of stomach. Given this epidemiological scenario of

In the hope that this may favor the planning and quality care to patients, we proposed the present study, directed to identify the time SB 525334 chemical information between symptoms, the search for care and the beginning of treatment in patients with stomach and colorectal cancer and the factors that interfered in these processes.MethodA quantitative descriptive, correlational studyperformed with 101 patients with purchase SB 202190 diagnosis of stomach or colorectal cancer of both sexes submitted to elective surgery, attended at a hospital specialized in the diagnosis and oncological treatment located in the city of S Paulo - Brazil, from July to December 2014. difficulties of the start of the treatment, hindering the recall of the situations experienced until there. Thus, despite the differences betweentumor types, it was decided to use them, since it was considered that the system of public health care used by patients was the same, added to the fact that the cited research contained the necessary statistical data, allowing us to adequately estimate the number of observations to be made. Thus, the sample calculation was based on the national study findings(10) in which the mean time between onset of symptoms and the first visit was 110 days with a standard deviation of 72.5 days. Thus, considering the time between symptoms and the first visit, it was estimated that it would be necessary to observe 90 patients, in order to obtain the average time of search for health care, with a margin of error of 15 days and a confidence interval of 95 . The project met the conditions of resolution 466/2012(11), Ethics being approved under by the Research number Committee, protocol24731414.3.0000.5392. Data were collected through a data collection instrument, which contained sociodemographic data and aspects related to diagnosis and treatment. Three oncology nurses, who analyzed the data collection instrument to evaluate its ability to achieve the proposed objectives and their clarity, suggested changes that were accepted by the authors. The data collection itself occurred through an interview of the patient or person in the preoperative period, after which they received expla.Nd mainly for cancer of stomach. Given this epidemiological scenario of high incidence and mortality and the limited number of publications on the subject we aimed to contribute to the identification of weaknesses and strengths of the system, in order to recognize qualities of the service offered to the population and also propose improvement measures. In the hope that this may favor the planning and quality care to patients, we proposed the present study, directed to identify the time between symptoms, the search for care and the beginning of treatment in patients with stomach and colorectal cancer and the factors that interfered in these processes.MethodA quantitative descriptive, correlational studyperformed with 101 patients with diagnosis of stomach or colorectal cancer of both sexes submitted to elective surgery, attended at a hospital specialized in the diagnosis and oncological treatment located in the city of S Paulo - Brazil, from July to December 2014. Inclusion criteria were: age equal to or older than 18 years and patients diagnosed with stomach or colorectal cancer hospitalized at the surgical clinic of the hospital selected for study to undergo elective surgeries for the treatment of cancer. Patients who had difficulties in understanding or communicating with the researcher and patients submitted to intestinal transit reconstruction surgery after the end of treatment were excluded, as these patients were distant from thewww.eerp.usp.br/rlaeCountries such as Japan, England, Canada and the United States of America (USA), which have established programs for the screening of stomach or colorectal cancer, have observed a significant decrease in morbimortality indexes associated with the disease due to the quality of their follow-up methods and the more efficient use of the available diagnostic tests, increasing the capacity of detection and removal of early adenomas and / or carcinomas(6-8).Valle TD, Turrini RNT, Poveda VB.